LAUREN GAUTHIER: Open Payments
NPI 1558025635 · LENOX, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 32 payments from 17 companies in 2025. Trend: 2023 $262 · 2024 $466 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $39 |
| Astellas Pharma US Inc | 2 | $35 |
| Novo Nordisk Inc | 2 | $32 |
| ABBVIE INC. | 2 | $31 |
| Seqirus USA Inc | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
Products named: Auvelity, CAPLYTA, REXULTI, FARXIGA, The Cologuard Plus Collection Kit, Veozah, VRAYLAR, BREZTRI.
Industry payments across MI — which companies pay providers there.
